Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
626 studies found for:    lupus
Show Display Options
Rank Status Study
21 Recruiting Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Tacrolimus vs. Mycophenolate mofetil for Induction Therapy in Lupus Nephritis
22 Completed Study of Methotrexate in Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Methotrexate and folic acid
23 Terminated The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: mycophenolate sodium;   Drug: cyclophosphamide
24 Completed A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic;   Lupus Erythematosus, Discoid;   Healthy
Interventions: Procedure: Skin biopsy;   Procedure: Blood collection;   Procedure: Urine collection
25 Completed A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic
Interventions: Drug: 1 mg/kg CNTO 136;   Drug: 4 mg/kg CNTO 136;   Drug: 10 mg/kg CNTO 136;   Drug: Placebo
26 Terminated Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus
Condition: Cutaneous Lupus Erythematosus
Intervention: Dietary Supplement: vitamin D
27 Terminated A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Lupuzor
28 Completed Anti-ficolin-3 Autoantibodies in Lupus Nephritis
Condition: Lupus Erythematosus, Systemic
Intervention: Other: Biological analysis
29 Completed The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease Patients
Conditions: Lupus Nephritis;   IgA Nephropathy
Intervention:
30 Completed
Has Results
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Biological: Sifalimumab 200 mg;   Biological: Sifalimumab 600 mg;   Biological: Sifalimumab 1,200 mg;   Other: Placebo
31 Completed Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease
Conditions: Immunologic Diseases;   Autoimmune Diseases;   Systemic Lupus Erythematosus;   Lupus Nephritis;   Lupus Glomerulonephritis
Intervention: Drug: Abetimus sodium (LJP 394)
32 Withdrawn Velcade for Proliferative Lupus Nephritis
Conditions: Lupus Nephritis;   Proteinuria;   Hematuria
Intervention: Drug: Velcade
33 Recruiting Web-based Genetic Research on Lupus
Condition: Systemic Lupus Erythematosus
Intervention:
34 Recruiting Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus
Condition: Systemic Lupus Erythematosus
Interventions: Other: computerized patient decision guide;   Other: usual care
35 Recruiting The Research Registry for Neonatal Lupus
Conditions: Neonatal Lupus;   Systemic Lupus Erythematosus;   Sjogren's Syndrome;   Congenital Heart Block
Intervention: Other: No intervention; observational
36 Recruiting Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
Conditions: Nephritis;   Lupus
Interventions: Drug: Leflunomide;   Drug: Azathioprine
37 Recruiting Duke Lupus Registry
Conditions: Systemic Lupus Erythematosus;   Cutaneous Lupus
Intervention:
38 Withdrawn Clinical Trial Treatment in Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: cyclosporine +mycophenolic acid+prednison;   Drug: Mycophenolic Acid + prednison
39 Not yet recruiting Evaluation and Prediction of Relapse Risk in Patients With Stable Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Other: Drug free;   Drug: HCQ;   Drug: GC+HCQ
40 Terminated Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: TRU-015

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years